Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.617 EUR | -0.16% | -1.28% | +13.21% |
May. 09 | Up Netweek, deal pushes Olidata; down Aedes | AN |
May. 09 | Mib bearish; Nexi confirmed as outperformer | AN |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.9 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- Most analysts recommend that the stock should be sold or reduced.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Integrated Hardware & Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.21% | 77.19M | - | ||
-1.62% | 30.06B | B- | ||
+13.49% | 8.7B | C | ||
-10.89% | 5.12B | - | - | |
-20.14% | 2.72B | - | - | |
-21.33% | 2.15B | B- | ||
+1.16% | 1.79B | D+ | ||
+70.61% | 1.77B | - | ||
-13.74% | 1.76B | B+ | ||
+5.46% | 1.51B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- OLI Stock
- Ratings Olidata S.p.A.